Drug-resistant tuberculosis: Patterns and predictors in extrapulmonary vs pulmonary TB

Background: Drug-resistant tuberculosis (DR-TB) poses a major challenge to global TB control, with increasing incidence and poor treatment outcomes. Differences in resistance patterns between pulmonary and extrapulmonary TB remain inadequately explored. Objective: To evaluate the patterns and predictors of drug-resistant tuberculosis in pulmonary and extrapulmonary TB patients. Methodology: This was a comparative cross-sectional study conducted at Sialkot medical college Sialkot from march 2025 to march 2026 including 266 patients diagnosed with tuberculosis. Results: Drug-sensitive TB was more common in extrapulmonary TB (67.3% vs 60.3%), while MDR-TB (20.5% vs 16.4%) and mono-resistance (14.1% vs 10.9%) were slightly higher in pulmonary TB. Patients with DR-TB were older (44.8 ± 13.9 vs 40.6 ± 14.4 years) and had lower BMI (20.7 ± 3.1 vs 21.9 ± 3.3 kg/m²). Previous TB treatment (59.2% vs 26.2%), diabetes (36.7% vs 22.6%), HIV positivity (20.4% vs 11.9%), and malnutrition (53.1% vs 31.0%) were significantly associated with DR-TB. Multivariable analysis identified previous treatment (AOR 3.42), malnutrition (AOR 2.76), low BMI (AOR 2.21), diabetes (AOR 1.94), HIV (AOR 1.88), and age >45 years (AOR 1.67) as independent predictors. Conclusion: Drug-resistant TB is influenced by multiple factors, with prior treatment being the most significant predictor. Both pulmonary and extrapulmonary TB require equal attention in resistance surveillance and management strategies.

Ҳали таржима қилинмаган